BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 35457062)

  • 1. Implications of Sphingolipid Metabolites in Kidney Diseases.
    Mallela SK; Merscher S; Fornoni A
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.
    Drexler Y; Molina J; Mitrofanova A; Fornoni A; Merscher S
    J Am Soc Nephrol; 2021 Jan; 32(1):9-31. PubMed ID: 33376112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational Aspects of Sphingolipid Metabolism in Renal Disorders.
    Abou Daher A; El Jalkh T; Eid AA; Fornoni A; Marples B; Zeidan YH
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and Beyond.
    Tolerico M; Merscher S; Fornoni A
    Cells; 2024 May; 13(11):. PubMed ID: 38891023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins.
    Hammad SM; Twal WO; Arif E; Semler AJ; Klein RL; Nihalani D
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32045989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte Sphingolipid Signaling in Nephrotic Syndrome.
    Li G; Kidd J; Gehr TWB; Li PL
    Cell Physiol Biochem; 2021 Apr; 55(S4):13-34. PubMed ID: 33861526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.
    Merscher S; Fornoni A
    Front Endocrinol (Lausanne); 2014; 5():127. PubMed ID: 25126087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS.
    Mitrofanova A; Drexler Y; Merscher S; Fornoni A
    J Cell Signal; 2020 Sep; 1(3):56-69. PubMed ID: 32914148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the role of the Target of Rapamycin signaling in sphingolipid metabolism.
    Teixeira V; Costa V
    Prog Lipid Res; 2016 Jan; 61():109-33. PubMed ID: 26703187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipids: regulators of crosstalk between apoptosis and autophagy.
    Young MM; Kester M; Wang HG
    J Lipid Res; 2013 Jan; 54(1):5-19. PubMed ID: 23152582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of sphingolipid metabolites in the homeostasis of steroid hormones and the maintenance of testicular functions.
    Wang D; Tang Y; Wang Z
    Front Endocrinol (Lausanne); 2023; 14():1170023. PubMed ID: 37008929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and regulation of bioactive sphingolipids.
    Heffernan-Stroud LA; Obeid LM
    Adv Enzyme Regul; 2011; 51(1):219-28. PubMed ID: 21035490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prohibitin Signaling at the Kidney Filtration Barrier.
    Ising C; Brinkkoetter PT
    Adv Exp Med Biol; 2017; 982():563-575. PubMed ID: 28551807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOL1 polymorphism modulates sphingolipid profile of human podocytes.
    Valsecchi M; Cazzetta V; Oriolo F; Lan X; Piazza R; Saleem MA; Singhal PC; Mavilio D; Mikulak J; Aureli M
    Glycoconj J; 2020 Dec; 37(6):729-744. PubMed ID: 32915357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids and mitochondrial apoptosis.
    Patwardhan GA; Beverly LJ; Siskind LJ
    J Bioenerg Biomembr; 2016 Apr; 48(2):153-68. PubMed ID: 25620271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingolipids in infectious diseases.
    Hanada K
    Jpn J Infect Dis; 2005 Jun; 58(3):131-48. PubMed ID: 15973004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bioactive lipids in kidney physiology and pathophysiology].
    Sałata D; Dołęgowska B
    Postepy Hig Med Dosw (Online); 2014 Jan; 68():73-83. PubMed ID: 24491898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of sphingosine kinase and sphingolipid signaling.
    Pitson SM
    Trends Biochem Sci; 2011 Feb; 36(2):97-107. PubMed ID: 20870412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipid metabolism and neutral sphingomyelinases.
    Airola MV; Hannun YA
    Handb Exp Pharmacol; 2013; (215):57-76. PubMed ID: 23579449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingolipids in cancer: regulation of pathogenesis and therapy.
    Ogretmen B
    FEBS Lett; 2006 Oct; 580(23):5467-76. PubMed ID: 16970943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.